Antithrombin deficiency, whether inherited or acquired, poses a significant risk factor for venous thromboembolism (VTE) by impairing the natural regulation of coagulation. As a critical plasma ...
INNOVANCE Antithrombin assay is a cutting-edge, ready-to-use chromogenic reagent for the automated determination of antithrombin (AT) activity. It is highly accurate even at low activity levels and ...
Hereditary antithrombin (AT) deficiency — an autosomal dominant disorder caused by SERPINC1 gene mutations — carries a high risk of venous thromboembolism. Treatment requires the long-term use of oral ...
In June 2021, Kenneth A. Bauer, MD, from Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School, spoke with Healio about the diagnosis and treatment of hereditary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results